Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb

Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb

Submitted by admin on April 1, 2020 - 9:33am
Source: 
Endpoints
News Tags: 
Gilead Sciences
CAR-T
Bristol-Meyers Squibb
Juno Therapeutics
patents
Headline: 
Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb
snippet: 

Gilead’s bid to overturn a jury verdict that ordered it to pay Bristol Myers Squibb about $752 million for CAR-T patents owned by its subsidiary Juno Therapeutics has ended in vain.

Do Not Allow Advertisers to Use My Personal information